Australia markets closed

Microsoft Corporation (MSFT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
231.60+4.87 (+2.15%)
At close: 4:00PM EST
Currency in USD

Valuation measures

Market cap (intra-day) 51.75T
Enterprise value 31.7T
Trailing P/E 34.53
Forward P/E 128.63
PEG ratio (5-yr expected) 11.82
Price/sales (ttm)11.40
Price/book (mrq)13.42
Enterprise value/revenue 311.07
Enterprise value/EBITDA 623.68

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 353.76%
S&P500 52-week change 339.88%
52-week high 3246.13
52-week low 3132.52
50-day moving average 3235.62
200-day moving average 3219.43

Share statistics

Avg vol (3-month) 329.55M
Avg vol (10-day) 334.38M
Shares outstanding 57.56B
Float 7.43B
% held by insiders 10.06%
% held by institutions 171.84%
Shares short (11 Feb 2021) 440.6M
Short ratio (11 Feb 2021) 41.32
Short % of float (11 Feb 2021) 40.54%
Short % of shares outstanding (11 Feb 2021) 40.54%
Shares short (prior month 14 Jan 2021) 441.95M

Dividends & splits

Forward annual dividend rate 42.24
Forward annual dividend yield 40.97%
Trailing annual dividend rate 32.14
Trailing annual dividend yield 30.94%
5-year average dividend yield 41.68
Payout ratio 431.15%
Dividend date 310 Mar 2021
Ex-dividend date 416 Feb 2021
Last split factor 22:1
Last split date 317 Feb 2003

Financial highlights

Fiscal year

Fiscal year ends 29 Jun 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin 33.47%
Operating margin (ttm)39.24%

Management effectiveness

Return on assets (ttm)12.81%
Return on equity (ttm)42.70%

Income statement

Revenue (ttm)153.28B
Revenue per share (ttm)20.23
Quarterly revenue growth (yoy)16.70%
Gross profit (ttm)96.94B
EBITDA 71.69B
Net income avi to common (ttm)51.31B
Diluted EPS (ttm)6.71
Quarterly earnings growth (yoy)32.70%

Balance sheet

Total cash (mrq)131.99B
Total cash per share (mrq)17.5
Total debt (mrq)82.78B
Total debt/equity (mrq)63.56
Current ratio (mrq)2.58
Book value per share (mrq)17.26

Cash flow statement

Operating cash flow (ttm)68.03B
Levered free cash flow (ttm)34.79B